ARYA SCIENCES ACQU CORP IV's ticker is ARYD and the CUSIP is G31659108. A total of 56 filers reported holding ARYA SCIENCES ACQU CORP IV in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,143,020 | +103.8% | 311,190 | +100.0% | 0.14% | -5.9% |
| Q3 2022 | $1,542,000 | +1.0% | 155,595 | 0.0% | 0.15% | +2.7% |
| Q2 2022 | $1,526,000 | +0.1% | 155,595 | 0.0% | 0.15% | +4.2% |
| Q1 2022 | $1,525,000 | -1.2% | 155,595 | 0.0% | 0.14% | +2.2% |
| Q4 2021 | $1,543,000 | – | 155,595 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 700,000 | $7,331,000 | 2.49% |
| Soleus Capital Management, L.P. | 300,000 | $3,142,000 | 0.57% |
| HealthCor Management, L.P. | 1,159,360 | $12,141,000 | 0.43% |
| Bain Capital Life Sciences Investors, LLC | 700,000 | $7,331,000 | 0.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $5,200,000 | 0.40% |
| Boxer Capital, LLC | 750,000 | $10,335,000 | 0.35% |
| Union Square Park Capital Management, LLC | 100,500 | $1,052,000 | 0.35% |
| Altium Capital Management LP | 100,000 | $1,047,000 | 0.29% |
| Consonance Capital Management LP | 250,000 | $2,618,000 | 0.28% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,000,000 | $10,473,000 | 0.23% |